Sevgi Gurkan
Fundador en Perfuse Therapeutics, Inc. .
Origen de la red de primer grado Sevgi Gurkan.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.
83
| Subsidiary | Investment Managers | 83 |
Icahn School of Medicine at Mount Sinai
8
| College/University | Other Consumer Services | 8 |
Perfuse Therapeutics, Inc.
 Perfuse Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Perfuse Therapeutics, Inc. operates as biotechnology company that focuses on retinal perfusion. The company was founded by Sevgi Gurkan in 2018 and is headquartered in San Francisco,CA.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Sevgi Gurkan a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Investment Managers | Founder Founder Portfolio Manager-Equities Analyst-Equity Private Equity Investor Portfolio Manager-Equities Portfolio Manager-Equities Analyst-Equity Portfolio Manager-Fixed Income Trading-Equity Portfolio Manager-Equities | |
| Stanford University | College/University | Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
Keystone Heart Ltd.
 Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | Medical Specialties | Director/Board Member Chairman Director/Board Member Director of Finance/CFO | |
| Yale University | College/University | Graduate Degree Undergraduate Degree Graduate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal Private Equity Analyst Comptroller/Controller/Auditor | |
| GELESIS INC | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Director of Finance/CFO | |
OrbiMed Capital LLC
 OrbiMed Capital LLC Financial ConglomeratesFinance Part of OrbiMed Advisors LLC, OrbiMed Capital LLC is a company based in New York, NY. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal Private Equity Analyst | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
OrbiMed Israel Partners LP
 OrbiMed Israel Partners LP Investment ManagersFinance OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements. | Investment Managers | Private Equity Analyst Founder Corporate Officer/Principal | |
| XTANT MEDICAL HOLDINGS, INC. | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA. | Biotechnology | Director/Board Member Chairman Director of Finance/CFO | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
RDD Pharma Ltd.
 RDD Pharma Ltd. Medical SpecialtiesHealth Technology RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel. | Medical Specialties | Director/Board Member Director/Board Member Director of Finance/CFO | |
| XYLO TECHNOLOGIES LTD | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
Cryterion Medical, Inc.
 Cryterion Medical, Inc. Medical/Nursing ServicesHealth Services Cryterion Medical, Inc. operates a medical laboratory that utilizes cryoablation platform. The company was founded on October 11, 2016 and is headquartered in Carlsbad, CA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| ENTERO HEALTHCARE SOLUTIONS LIMITED | Medical Distributors | Director/Board Member Director/Board Member | |
| New York University | College/University | Undergraduate Degree Masters Business Admin | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Graduate Degree | |
| ACUTUS MEDICAL, INC. | Medical Specialties | Director/Board Member Chief Executive Officer | |
Credit Suisse (Hong Kong) Ltd.
 Credit Suisse (Hong Kong) Ltd. Investment Banks/BrokersFinance Credit Suisse (Hong Kong) Ltd. (CSHK) is a securities brokerage firm headquartered Hong Kong. The firm is a subsidiary of Credit Suisse AG, which is owned by Credit Suisse Group AG (SWX: CSGN; ADR: CS) in Switzerland. CSHK provides corporate and institutional investors with sales, trading, financing, prime services, and market-making in global equities, as well as equities-related securities, options, futures, risk management, and hedging products. Their client-focused platform offers issuer and investor clients access to distribution, trading, and origination capabilities across various markets globally. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity | |
| University College Dublin | College/University | Undergraduate Degree Undergraduate Degree | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Chairman | |
| IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. Packaged SoftwareTechnology Services Odyssey Therapeutics, Inc. is a biotechnology company that specializes in discovering, developing, and commercializing immunomodulators and oncology medicines. The company is based in Medfield, MA and has subsidiaries in the United Kingdom. The company is composed of a team of drug hunters, scientists, and industry leaders in foundational biology, chemistry, and data sciences. Odyssey Therapeutics aims to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. Odyssey Therapeutics was founded by David L. Pompliano, Gary D. Glick, and Melissa Merrick, with Gary D. Glick serving as the CEO since incorporation. | Packaged Software | Director/Board Member Director/Board Member | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
| The Johns Hopkins University | College/University | Doctorate Degree Doctorate Degree | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| THESEUS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Gwynant Therapeutics
 Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Gwynant Therapeutics develops new small molecules for oncology targets. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SONENDO, INC. | Medical Specialties | Director/Board Member Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 41 |
| Israel | 5 |
| Reino Unido | 2 |
| Alemania | 2 |
| India | 2 |
Sectorial
| Health Technology | 27 |
| Consumer Services | 16 |
| Finance | 7 |
| Health Services | 2 |
| Distribution Services | 2 |
Operativa
| Director/Board Member | 450 |
| Corporate Officer/Principal | 113 |
| Independent Dir/Board Member | 112 |
| Private Equity Investor | 98 |
| Undergraduate Degree | 83 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Jonathan Silverstein | 42 |
| Peter Thompson | 39 |
| Chau Khuong | 38 |
| Iain Dukes | 32 |
| Erez Chimovits | 30 |
| Sunny Sharma | 29 |
| Rishi Gupta | 29 |
| Guo-Liang Yu | 27 |
| Nissim Darvish | 27 |
| David Bonita | 27 |
| Christy Shaffer | 26 |
| Steve Yecies | 23 |
| Dina Chaya | 23 |
| Eric Rose | 21 |
- Bolsa de valores
- Insiders
- Sevgi Gurkan
- Conexiones Empresas
